I have been through one internal appeal already and would like to do the next one properly.
I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked.
Assume no laboratory access beyond what I can pay a third party for.
Which parts of this are load-bearing and which parts are habit?
Answer first: a prior authorisation is a documentation exercise against published criteria, and it is won or lost on whether the record contains the required elements.
Obtain the medical policy for the specific drug and plan first. It lists the required diagnosis codes, thresholds, documented durations and any prerequisite therapy, and it is the checklist the reviewer works from.
| Line | Brand, insured | Compounded, subscription | Research-grade, self-tested |
|---|---|---|---|
| Product | Copay × 12 | Monthly fee × 12 | Vials × unit price |
| Consultation | Covered or copay | Bundled | Not applicable |
| Monitoring labs | Often covered | Usually not | Self-funded |
| Independent testing | Not applicable | Optional | Essential; per lot |
| Shipping | Pharmacy | Included | Per order |
| Dominant cost | Copay structure | Subscription fee | Testing |
The part that matters: the denial letter states a specific reason. The appeal should address that reason first and explicitly, with the missing evidence attached, rather than restating the original case.
Peer-to-peer review is a standard step in utilisation-management processes and resolves a meaningful share of disputes.
Get the criteria first. A request written blind is a request written badly.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsThe honest answer is that the process rewards preparation and punishes improvisation.
Where prerequisite therapy is required, the record needs the agent, the dates, the dose and the reason it was stopped. "Tried and failed" without those four elements is not documentation.
The underlying point is that each criterion must be evidenced in the clinical record, dated, before the request. A criterion asserted in a covering letter but absent from the notes is the commonest reason for a denial.
A prescriber has to submit the request; this is a description of what makes one succeed, not a substitute for one.
Evidence every criterion in the dated record, not in a covering letter.
The relevant point is that most denials cite a missing element rather than a clinical disagreement, and missing elements are fixable.
Submit the supporting documents with the request rather than waiting to be asked. Requests denied for insufficient information are denials that a complete submission would have avoided.
Track the deadlines. Appeal windows are finite, and a well-founded appeal filed late is worth nothing at all.
A substantial proportion of denials cite incomplete documentation rather than clinical non-eligibility, which is why complete first submissions matter.
Research-use compounds are outside this framework entirely and are not approved for human use.
Attach everything on the first submission. Incomplete is the commonest denial.
edited 17 Apr 2026 by Dr_Ingrid_Baumgartner — added the citation requested in comments
Peer-to-peer review is available in many systems and is underused.
Approvals expire. Note the renewal date when the approval arrives, because a lapse mid-treatment is administratively identical to a fresh denial.
The denial reason is the appeal specification. Address it directly.
The short version: get the criteria, evidence each one in the record, submit with the documentation attached, and appeal a denial with the reason addressed.
A peer-to-peer review — the prescriber speaking to the plan's reviewer — is available in many systems and resolves a meaningful proportion of denials that a written appeal would not.
Medical policies stating prior-authorisation criteria are published by plans and are obtainable before submission.
The caveat is that this is administrative navigation and nothing here is clinical or legal advice.
Diarise the renewal date the moment approval arrives.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.